To include your compound in the COVID-19 Resource Center, submit it here.

Ferric citrate regulatory update

FDA approved an NDA from Keryx for ferric citrate to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis. FDA contraindicated the

Read the full 243 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE